MOG and myeloid sarcoma: Furthermore, we aimed to provide proof-of-concept for the use of myelin mRNA-electroporated tolDC as a potential treatment for MS by assessment of the efficacy of MOG mRNA-electroporated tolDC to dampen pathogenic T cell responses in an animal model of MS, i.e., EAE.